Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 09, 2026 20:00 ET | Source: Shanghai EpimAb Biotherapeutics Co., Ltd.

EpimAb Biotherapeutics Announces the First CTA Filing of a FIT-IG® Bispecific Antibody by its License Partner Almirall

SHANGHAI, Feb. 10, 2026 (GLOBE NEWSWIRE) -- EpimAb Biotherapeutics, a clinical stage biopharmaceutical company specializing in the development of novel multispecific antibodies, today announced the...
January 21, 2026 04:52 ET | Source: Research and Markets

U.S. Bispecific Antibodies Forecast Report 2025-2033: Market to Grow by Over $260 Billion, Driven by Increased Cancer and Autoimmune Diseases, FDA Approvals, and Strategic Partnerships

Dublin, Jan. 21, 2026 (GLOBE NEWSWIRE) -- The "U.S. Bispecific Antibodies Market Forecast to 2033" report has been added to ResearchAndMarkets.com's offering.The U.S. bispecific antibodies market...
December 10, 2025 09:15 ET | Source: Research and Markets

China Leads Therapeutic Access with 74 Approved Immuno-Oncology Agents

Dublin, Dec. 10, 2025 (GLOBE NEWSWIRE) -- The "Strategic Intelligence: Immuno-oncology (2025)" has been added to ResearchAndMarkets.com's offering. The latest report delves into the dynamic...
December 02, 2025 06:41 ET | Source: Research and Markets

Human Leukocyte Antigen (HLA) Targeted Therapy Market Research 2026: Advances Driven by Novel CAR-Treg and Bispecific T-Cell Engager Programs from Quell Therapeutics and Daiichi Sankyo

Dublin, Dec. 02, 2025 (GLOBE NEWSWIRE) -- The "Human Leukocyte Antigen (HLA) Targeted Therapy, Clinical Trials, Therapeutic Approaches & Market Opportunity Insight 2026" report has been added to...
December 01, 2025 06:03 ET | Source: Research and Markets

$16.81 Bn Bispecific Antibodies Market Industry Trends and Global Forecasts, 2035 - Market Expanding Rapidly with 400+ Candidates in Development and 85+ Technology Platforms

Dublin, Dec. 01, 2025 (GLOBE NEWSWIRE) -- The "Bispecific Antibodies Market Industry Trends and Global Forecasts to 2035: By Therapeutic Area, Mechanism of Action, Target Antigen, Antibody Format,...
November 27, 2025 09:02 ET | Source: Research and Markets

PD-L1 X 4-1BB (CD137) Bispecific Antibodies Pipeline and Competitive Intelligence Report 2025

Dublin, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The "Pipeline of PD-L1 x 4-1BB (CD137) Bispecific Antibodies" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence...
November 27, 2025 09:01 ET | Source: Research and Markets

DLL3-Targeted Immunotherapy Competitor Analysis Report 2025: The Field Still is in Mid-stage Clinical Development Without Clear Leader in the Competition

Dublin, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The "DLL3-Targeted Immunotherapy: a Competitor Analysis" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence report...
November 27, 2025 08:56 ET | Source: Research and Markets

Folate Receptor Alpha (FRa) Targeted Therapy Competitor Analysis Report 2025: Next Generation Cell Therapy Modalities and Radiopharmaceuticals are Advancing in the Pipeline

Dublin, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The "Folate Receptor alpha (FRa) Targeted Therapy: a Competitor Analysis" report has been added to ResearchAndMarkets.com's offering.This competitive...
November 27, 2025 08:43 ET | Source: Research and Markets

KLK2-Targeted Immunotherapies Pipeline Competitive Intelligence Report 2025

Dublin, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The "Pipeline of KLK2-Targeted Immunotherapies" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence report about...
October 09, 2025 04:23 ET | Source: Research and Markets

Bispecific Antibodies Market - Global Forecast 2025-2032, Profiles of Key Players - F. Hoffmann-La Roche, Amgen, Janssen Biotech, Pfizer, AbbVie, Regeneron, MacroGenics, AstraZeneca, Merck, and Genmab

Dublin, Oct. 09, 2025 (GLOBE NEWSWIRE) -- The "Bispecific Antibodies Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering. The global bispecific...